Summary
PD0325901 is a small molecule inhibitor of the mitogen-activated protein kinase kinase (MAPK/ERK kinase or MEK) with potential antineoplastic activity. PD0325901, a derivative of MEK inhibitor CI-1040, selectively binds to and inhibits MEK, which may result in the inhibition of the phosphorylation and activation of MAPK/ERK and the inhibition of tumor cell proliferation It has been shown to improve the reprogramming efficiency of iPSC.
Form
Liquid
Buffer
DMSO
Preservative
No Preservative
Storage
Store at -20ºC. Maintain under sterile conditions.
Concentration
0.5 mM (Please refer to the vial label for the specific concentration.)
Note
For laboratory research use only. Not for any clinical, therapeutic, or diagnostic use in humans or animals. Not for animal or human consumption.
Purchasers shall not, and agree not to enable third parties to, analyze, copy, reverse engineer or otherwise attempt to determine the structure or sequence of the product.